(MENAFN - Comserve) Shibuya-ku, Tokyo, Japan, Japan, Apr 26, 2021, 05:35 /Comserve / Competitive Analysis: Roche, Pfizer, Abbvie, Johnson, Sanofi, Merck, Novartis, Gilead, GSK, Amgen
Dalbavancin Market By Product Type (Intravenous Therapy, Oral Type) and Application (Skin Infection, Soft Tissue Infection, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Dalbavancin Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Dalbavancin is a second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin, the most widely used and one of the few treatments available to patients suffering with methicillin-resistant Staphylococcus aureus (MRSA).
stevenFebruary 12, 2021 13
Global “Virology market Report” has been featured by Syndicate Market Research Organization and has Extensive information on factors that will amplify the growth of Virology Market over the upcoming seven years. It also has an In-depth analysis of the industry’s competitive landscape, detailed information about different drivers, restraints, and opportunities. It Furnishes detailed information on the factors that will restrain the growth of Virology manufacturers
(
Abbott Diagnostics, Werfen Group S.A., QIAGEN N.V, Roche Diagnostics, Alere Inc, Bio-Rad Laboratories, Instrumentation Laboratory (IL), Ortho Clinical Diagnostics (OCD), Sysmex Corporation, BioMérieux Inc., Siemens Healthineers, Thermo FisherScientific, Hologic, Becton Dickinson and Company (BD), Beckman Coulter Inc. / Danaher ). The report covers key strategic Points Regarding developments of the market including acquisitions & mergers, agreements, partnerships, new type l